(RTTNews) - Blueprint Medicines Corp. (BPMC) announced Wednesday positive top-line results from PIONEER trial of AYVAKIT (avapritinib) in patients with non-advanced systemic mastocytosis or SM.

Blueprint Medicines stock was soaring Monday after French drugmaker Sanofi said it had agreed to buy the biotech company for $9.5 billion. Shares in Blueprint jumped 26% to $127.77 in early ...

Senator Kyrsten Sinema of Arizona, another key Democrat, had previously said she would not support a final $3.5 trillion package. Like Mr. Manchin, she framed her vote in support of the budget ...

Key Takeaways From Blueprint Medicines Analyst Ratings November 14, 2024 — 12:00 pm EST Written by Benzinga Insights for Benzinga -> ...

House approves key budget blueprint to unlock Trump’s agenda By Sarah Ferris and Annie Grayer, CNN 4 min read Updated 12:34 PM EDT, Thu April 10, 2025 Link Copied! Follow: ...

Blueprint Medicines and Deciphera were both founded on the promise of kinase inhibition, and have captured investors’ imagination, respectively raising $169m in a float and $175m in private money.